The Ulster Genome Project holds samples with integrated clinical data and robust laboratory measures of genomic, proteomic and metabolomic data.
We aim to facilitate the discovery and validation of biomarkers for disease predisposition and effectiveness of therapy.
Our research programme includes the recruitment of ~7000 patients and the use of advanced data analysis techniques to better inform the diagnoses and treatment of disease.